Altimmune (ALT) Shareholder's Equity (2010 - 2026)
Altimmune (ALT) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Altimmune |
336.67 Mn |
336.67 Mn |
- |
283.99 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
283.99 Mn |
| Dec 31, 2025 |
224.89 Mn |
| Sep 30, 2025 |
185.60 Mn |
| Jun 30, 2025 |
161.37 Mn |
| Mar 31, 2025 |
142.16 Mn |
| Dec 31, 2024 |
123.51 Mn |
| Sep 30, 2024 |
133.38 Mn |
| Jun 30, 2024 |
152.53 Mn |
| Mar 31, 2024 |
172.94 Mn |
| Dec 31, 2023 |
194.10 Mn |
| Sep 30, 2023 |
150.40 Mn |
| Jun 30, 2023 |
167.71 Mn |
| Mar 31, 2023 |
167.73 Mn |
| Dec 31, 2022 |
185.29 Mn |
| Sep 30, 2022 |
205.03 Mn |
| Jun 30, 2022 |
194.54 Mn |
| Mar 31, 2022 |
184.87 Mn |
| Dec 31, 2021 |
199.14 Mn |
| Sep 30, 2021 |
209.26 Mn |
| Jun 30, 2021 |
241.28 Mn |
